Literature DB >> 25898044

Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission.

Genevieve G Fouda1, Coleen K Cunningham2, Sallie R Permar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25898044      PMCID: PMC4520313          DOI: 10.1001/jama.2015.1382

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Authors:  Barton F Haynes; Peter B Gilbert; M Juliana McElrath; Susan Zolla-Pazner; Georgia D Tomaras; S Munir Alam; David T Evans; David C Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua-Xin Liao; Anthony L DeVico; George K Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L Robb; Viseth Ngauy; Mark S de Souza; Robert Paris; Guido Ferrari; Robert T Bailer; Kelly A Soderberg; Charla Andrews; Phillip W Berman; Nicole Frahm; Stephen C De Rosa; Michael D Alpert; Nicole L Yates; Xiaoying Shen; Richard A Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L Michael; Jerome H Kim
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

2.  Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Authors:  Risa M Hoffman; Vivian Black; Karl Technau; Karin Joan van der Merwe; Judith Currier; Ashraf Coovadia; Matthew Chersich
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

3.  Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.

Authors:  C K Cunningham; D W Wara; M Kang; T Fenton; E Hawkins; J McNamara; L Mofenson; A M Duliege; D Francis; E J McFarland; W Borkowsky
Journal:  Clin Infect Dis       Date:  2001-02-28       Impact factor: 9.079

4.  The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.

Authors:  Leigh F Johnson; Kathryn Stinson; Marie-Louise Newell; Ruth M Bland; Harry Moultrie; Mary-Ann Davies; Thomas M Rehle; Rob E Dorrington; Gayle G Sherman
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

5.  HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.

Authors:  Elizabeth J McFarland; Daniel C Johnson; Petronella Muresan; Terence Fenton; Georgia D Tomaras; James McNamara; Jennifer S Read; Steven D Douglas; Jaime Deville; Marc Gurwith; Sanjay Gurunathan; John S Lambert
Journal:  AIDS       Date:  2006-07-13       Impact factor: 4.177

6.  Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa.

Authors:  Kenneth Kintu; Philip Andrew; Philippa Musoke; Paul Richardson; Brenda Asiimwe-Kateera; Teopista Nakyanzi; Lei Wang; Mary Glenn Fowler; Lynda Emel; San-San Ou; Lynn Baglyos; Sanjay Gurunathan; Sheryl Zwerski; Jay Brooks Jackson; Laura Guay
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

7.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

8.  What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs.

Authors:  Mary Mahy; John Stover; Karusa Kiragu; Chika Hayashi; Priscilla Akwara; Chewe Luo; Karen Stanecki; Rene Ekpini; Nathan Shaffer
Journal:  Sex Transm Infect       Date:  2010-12       Impact factor: 3.519

9.  Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Authors:  Genevieve G Fouda; Coleen K Cunningham; Elizabeth J McFarland; William Borkowsky; Petronella Muresan; Justin Pollara; Lin Ye Song; Brooke E Liebl; Kaylan Whitaker; Xiaoying Shen; Nathan A Vandergrift; R Glenn Overman; Nicole L Yates; M Anthony Moody; Carrie Fry; Jerome H Kim; Nelson L Michael; Merlin Robb; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Hua-Xin Liao; Barton F Haynes; David C Montefiori; Guido Ferrari; Georgia D Tomaras; Sallie R Permar
Journal:  J Infect Dis       Date:  2014-08-27       Impact factor: 7.759

10.  PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi.

Authors:  Irene N Njuguna; Gwen Ambler; Marie Reilly; Beatrice Ondondo; Mercy Kanyugo; Barbara Lohman-Payne; Christine Gichuhi; Nicola Borthwick; Antony Black; Shams-Rony Mehedi; Jiyu Sun; Elizabeth Maleche-Obimbo; Bhavna Chohan; Grace C John-Stewart; Walter Jaoko; Tomáš Hanke
Journal:  Vaccine       Date:  2014-08-27       Impact factor: 3.641

  10 in total
  2 in total

1.  Ontogeny of CD4+ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1-Exposed Ugandan Infants.

Authors:  Elizabeth J McFarland; Tina M Powell; Carolyne Onyango-Makumbi; Weiming Zhang; Kelsey Melander; Prossy Naluyima; Samuel Okurut; Michael A Eller; Mary Glenn Fowler; Edward N Janoff
Journal:  J Infect Dis       Date:  2017-02-01       Impact factor: 5.226

2.  Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.

Authors:  Amit Kumar; Claire E P Smith; Elena E Giorgi; Joshua Eudailey; David R Martinez; Karina Yusim; Ayooluwa O Douglas; Lisa Stamper; Erin McGuire; Celia C LaBranche; David C Montefiori; Genevieve G Fouda; Feng Gao; Sallie R Permar
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.